Fibromyalgia in Patient With Impaired Fasting Glucose

H

Hitit University

Status

Completed

Conditions

Fibromyalgia

Treatments

Diagnostic Test: oral glucose tolerance test (OGTT)

Study type

Observational

Funder types

Other

Identifiers

NCT03871946
Hitit University

Details and patient eligibility

About

To assess the frequency of fibromyalgia among women with impaired fasting glucose.

Full description

Objective: To assess the frequency of fibromyalgia among women with impaired fasting glucose. Materials and Methods: The sample was selected from the patients who applied to the Internal Medicine clinic and whose fasting blood glucose level were ≥100 and <126 mg/dL in their routine examination [Group1 ] and patients whose fasting blood glucose were less than 100 constituted the control group [Group2 ]. Oral glucose tolerance test [OGTT ] has been applied to patients with impaired fasting glucose and whose 2nd hour OGTT levels were under 140 has been included. Patients were evaluated in terms of fibromyalgia according to modified 2010 ACR Fibromiyalgia Criteria. Functional status was assessed by using the Fibromyalgia Impact Questionnaire [FIQ ].

Enrollment

146 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • the study group subjects: fasting blood glucose level was between 100 and 126 mg/dL;
  • the control group subjects: fasting blood glucose level was < 100 mg/dL.

Exclusion criteria

  • Patients with a severe systemic disease (chronic kidney disease, liver disease etc. ),
  • psychiatric disease,
  • hypothyroidism or hyperthyroidism,
  • any connective tissue disease
  • patients who used medications that influenced the fibromyalgia symptoms, such as analgesics, antidepressants, and anticonvulsive medications

Trial design

146 participants in 2 patient groups

Experimental group
Description:
Experimental group subjects with impaired fasting glucose (IFG) (Group 1) underwent an oral glucose tolerance test (OGTT), and patients with levels > 140 mg/dL at the 2nd hour were excluded because they were diagnosed with "impaired glucose tolerance"
Treatment:
Diagnostic Test: oral glucose tolerance test (OGTT)
control group
Description:
The control group (Group 2) comprised 73 patients whose fasting blood glucose level was <100 mg/dL and who agreed to participate in the study.
Treatment:
Diagnostic Test: oral glucose tolerance test (OGTT)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems